Nihan Çarçak Selected Research

Nucleotides

1/2019

Cav 3.2 T-type calcium channel mutation influences kindling-induced thalamic neuronal firing patterns in Genetic Absence Epilepsy Rats From Strasbourg.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nihan Çarçak Research Topics

Disease

7	Seizures (Absence Seizure) 01/2023 - 01/2018
7	Absence Epilepsy (Childhood Absence Epilepsy) 01/2023 - 01/2018
3	Epilepsy (Aura) 01/2023 - 11/2018
1	Cognitive Dysfunction 01/2023
1	Encephalitis (Encephalitis, Rasmussen) 01/2023
1	Glioma (Gliomas) 01/2023
1	Autoimmune Diseases of the Nervous System 01/2023
1	Neuroinflammatory Diseases 11/2018

Drug/Important Bio-Agent (IBA)

2	ICI D2788IBA 01/2022 - 01/2018
2	Cyclic NucleotidesIBA 01/2022 - 01/2018
2	Cyclic Nucleotide-Gated Cation ChannelsIBA 01/2022 - 01/2018
1	AutoantibodiesIBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	OrexinsIBA 01/2023
1	Adenosine (Adenocard)FDA LinkGeneric 01/2023
1	Adenosine KinaseIBA 01/2023
1	Adenosine Triphosphatases (ATPase)IBA 01/2023
1	AntibodiesIBA 01/2023
1	EnzymesIBA 01/2023
1	gamma-Aminobutyric Acid (GABA)IBA 01/2023
1	Immunoglobulin G (IgG)IBA 01/2023
1	Leucine (L-Leucine)FDA Link 01/2023
1	NeuropeptidesIBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	Glutamic Acid (Glutamate)FDA Link 01/2023
1	YNT-185IBA 01/2023
1	Lacosamide FDA Link 01/2022
1	Sodium Channel BlockersIBA 01/2022
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 12/2020
1	Adrenergic Receptors (Adrenergic Receptor)IBA 12/2020
1	atipamezoleIBA 12/2020
1	NucleotidesIBA 01/2019
1	T-Type Calcium Channels (T-Type Calcium Channel)IBA 01/2019
1	fasudil (AT 877)IBA 11/2018
1	Y 27632IBA 11/2018
1	rho-Associated KinasesIBA 11/2018
1	ElementsIBA 01/2018

Therapy/Procedure

1	Therapeutics 01/2018